Human Metabolome Technologies, Inc. announced earnings results for the first quarter ended June 30, 2018. For the quarter, the company reported net sales of ¥150 million against ¥117 million a year ago. Operating loss was ¥129 million against ¥130 million a year ago. Ordinary loss was ¥126 million against ¥131 million a year ago. Loss attributable to owners of parent was ¥127 million or ¥21.82 per basic share against ¥132 million or ¥22.74 per basic share a year ago.

The company provided consolidated earnings guidance for the full year ending March 31, 2019. For the period, the company expects net sales of ¥1,100 million, operating loss of ¥285 million, ordinary loss of ¥285 million and loss attributable to owners of parent of ¥295 million or ¥50.59 per basic share.